Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?

Authors

  • Nina Pejic Clinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia https://orcid.org/0000-0003-1557-3197
  • Milica Stojkovic Lalosevic Clinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia
  • Milos Stulic Clinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia https://orcid.org/0000-0002-9554-2106
  • Milica Culafic Clinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia
  • Djordje Culafic Clinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia

DOI:

https://doi.org/10.3855/jidc.16401

Keywords:

COVID-19, microscopic polyangiitis, interstitial lung disease

Abstract

Introduction: COVID-19 is an infectious disease, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and there have been outbreaks worldwide. The presentation may include unspecific and mild symptoms, myalgia, headaches, high fever, dry cough, severe dyspnea and acute respiratory distress syndrome (ARDS).

Case study: We present a rare case of microscopic polyangiitis (MPA) with interstitial lung disease and without renal involvement misdiagnosed as COVID-19.

Conclusions: Differential diagnosis of COVID-19 is extremely important, and must be correctly identified in order to proceed with correct treatment.

Downloads

Published

2022-09-30

How to Cite

1.
Pejic N, Stojkovic Lalosevic M, Stulic M, Culafic M, Culafic D (2022) Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?. J Infect Dev Ctries 16:1530–1532. doi: 10.3855/jidc.16401

Issue

Section

Case Reports